--- title: "Anteris Technologies Global (AVR) stock and investor profile" url: "https://aibio.space/companies/anteris-technologies-global/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Anteris Technologies Global Corp. (NASDAQ: AVR), United States. Listing facts, related biotech companies and news on aibio.space." --- AVR Anteris Technologies Global Corp. NASDAQ · United States # Anteris Technologies Global (AVR) news Anteris Technologies Global Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker AVR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Anteris Technologies Global news We have not published a story on Anteris Technologies Global yet. When there is news, it will appear here. ## Anteris Technologies Global at a glance - **Ticker**: AVR - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $249.9 million ### Related companies - [CHARLES RIVER LABORATORIES INTERNATIONAL, INC.](https://aibio.space/companies/charles-river-laboratories-international/) NYSE: CRL - [INTERPACE BIOSCIENCES, INC.](https://aibio.space/companies/interpace-biosciences/) OTC: IDXG - [BIOHARVEST SCIENCES INC.](https://aibio.space/companies/bioharvest-sciences/) NASDAQ: BHST - [One World Products](https://aibio.space/companies/one-world-products/) OTC: OWPC - [Cytosorbents](https://aibio.space/companies/cytosorbents/) NASDAQ: CTSO - [Research Alliance Corp III](https://aibio.space/companies/research-alliance-iii/) NASDAQ: RACC - [ProPhase Labs](https://aibio.space/companies/prophase-labs/) OTC: PRPH - [INTELLIGENT BIO SOLUTIONS INC.](https://aibio.space/companies/intelligent-bio-solutions/) NASDAQ: INBS ### Also on NASDAQ - [Sionna Therapeutics](https://aibio.space/companies/sionna-therapeutics/) SION - [BIOHARVEST SCIENCES INC.](https://aibio.space/companies/bioharvest-sciences/) BHST - [Evogene](https://aibio.space/companies/evogene/) EVGN - [CytoMed Therapeutics](https://aibio.space/companies/cytomed-therapeutics/) GDTC - [MannKind](https://aibio.space/companies/mannkind/) MNKD - [Biodexa Pharmaceuticals](https://aibio.space/companies/biodexa-pharmaceuticals/) BDRX ## Anteris Technologies Global annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$1.9 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | [$2.7 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | | Research and development | [$69.1 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | [$51.5 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | | Net income (loss) | [-$94.1 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | [-$76.3 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | | Cash from operations | [-$77.8 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | [-$61.2 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126006977/) | | Cash and equivalents | [$6.7 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036126032232/) | [$70.5 million](https://www.sec.gov/Archives/edgar/data/2011514/000114036125018701/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $249.9 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Anteris Technologies Global What is the ticker symbol of Anteris Technologies Global? Anteris Technologies Global Corp. trades under the ticker AVR on NASDAQ. Where is Anteris Technologies Global listed? Anteris Technologies Global Corp. is listed on NASDAQ. Which country or territory is Anteris Technologies Global listed under? Our directory records Anteris Technologies Global Corp. under United States. Does aibio.space cover Anteris Technologies Global? aibio.space lists Anteris Technologies Global Corp. among 2,820 public biotech companies and publishes its news here as stories appear. What was Anteris Technologies Global's revenue last year? $1.9 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Anteris Technologies Global profitable? Anteris Technologies Global Corp. reported a net loss of $94.1 million for the fiscal year ended Dec 31, 2025, and used $77.8 million of cash in operations, per its annual report to the SEC. How much does Anteris Technologies Global spend on research and development? $69.1 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Anteris Technologies Global have? $249.9 million in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: Anteris Technologies Global Members talk about Anteris Technologies Global (AVR). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Anteris Technologies Global, newest first. Each line links the filing it comes from. 1. 2026-07-01 Financings Set up an at-the-market program to sell shares over time. SEC Form S-3ASR. [Source](https://www.sec.gov/Archives/edgar/data/2011514/000114036126027252/ny20076823x1_s3asr.htm) 2. 2026-05-22 Financings Reported a financing. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/2011514/000114036126022632/ny20074564x1_424b5.htm) 3. 2026-04-29 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02). [Source](https://www.sec.gov/Archives/edgar/data/2011514/000114036126017846/ef20071159_8k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:AVR on TradingView](https://www.tradingview.com/symbols/NASDAQ-AVR/). ## Listing details Anteris Technologies Global Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker AVR, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Anteris Technologies Global Corp. - **Ticker**: AVR - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/anteris-technologies-global/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Anteris Technologies Global (AVR) stock and investor profile", 2026-10-31, https://aibio.space/companies/anteris-technologies-global/